We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





At Least One Effective COVID-19 Vaccine to Be Available by 2021, But Only in Limited Quantities, Says WHO

By HospiMedica International staff writers
Posted on 16 Oct 2020
There would be at least one safe and effective COVID-19 vaccine by 2021, although it will be available in “limited quantities” which may require priority to be given to vulnerable people and result in a delay in the immunization of healthy, young people until 2022.

The World Health Organization’s (WHO Geneva, Switzerland) chief scientist, Dr. More...
Soumya Swaminathan, has warned that young and healthy people should be prepared to wait for immunization for well over a year. Speaking at a WHO social media event, Dr. Swaminathan said that despite the global efforts for developing a COVID-19 vaccine and several candidates undergoing clinical trials, speedy and mass inoculation was highly unlikely. Health-care workers and others on the front lines would be the first ones to receive a COVID-19 vaccine, followed by the elderly or sick. The WHO would work along with governments and international organizations to ensure that the people facing the highest risk receive priority for the vaccine. This means that the remaining young population who are in sound health would have to wait longer to be vaccinated.

“Most people agree, it’s starting with health care workers, and front-line workers, but even there, you need to define which of them are at highest risk, and then the elderly, and so on,” said Dr. Swaminathan. “There will be a lot of guidance coming out, but I think an average person, a healthy young person might have to wait until 2022 to get a vaccine.”

Separately, Robin Nandy, the chief of immunization at UNICEF, said in an interview that COVID-19 vaccines would be initially available only in small quantities that would be insufficient to vaccinate the world’s entire population.

“Vaccines are going to be available in the initial years in too small quantities to vaccinate the seven billion people we have across the globe today,” Robin Nandy, the chief of immunization at UNICEF, said in an interview. “Vaccines will arrive in dribs and drabs.”

People providing essential services such as health care and education should be among the first to be vaccinated, he said. “We have to live with the pandemic for a while, so we need these systems to continue."

Related Links:
World Health Organization


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.